Korea Innovation Foundation selects 2 innovative technology companies, NARMA and SPS for Global Technology Commercialization Support Program(North America)
November 12, 2024 - 21:00
Through this initiative, NARMA and SPS will receive tailored support designed to address their specific needs, helping them navigate the complexities of entering a new market. This support includes mentorship, resources, and strategic guidance to ensure these companies can effectively leverage their technological advancements and innovations.
By fostering collaboration and providing essential tools, the program seeks to empower these companies to thrive in the competitive landscape of North America, ultimately contributing to their growth and success. The selection of NARMA and SPS highlights the foundation's commitment to promoting innovative technologies and supporting their journey toward global commercialization.
MORE NEWS
April 21, 2026 - 17:12
Technology Guide: Modern cellular analysis in early drug discoveryThe initial stages of drug discovery are being transformed by a new generation of cellular analysis technologies. By moving beyond traditional, one-dimensional assays, scientists are now able to...
April 21, 2026 - 04:09
New technology could help Nancy Guthrie case: GenealogistA leading forensic genealogist has announced that emerging DNA technology could finally unlock the mystery surrounding Nancy Guthrie, a case that has remained cold for over three decades. The...
April 20, 2026 - 19:27
Navigating the AI Regulatory Maze: Experts Weigh In on Innovation and PolicyThe rapid advancement of artificial intelligence has sparked a complex global debate on how best to govern the technology. According to analysts Anna Viñals Musquera and Scott Babwah Brennen, a...
April 20, 2026 - 10:07
New technology is increasing the speed and depth of cyber attacksFinancial services groups are having to adapt rapidly to a changing threat landscape, as new technology dramatically increases the speed and depth of cyber attacks. The industry, a perennial target...